Evidence-generation workflow (PRD §17); Rejected is a terminal branch from any review stage.
Review stages passed, derived from workflow position
Rejected — Rejected: sample consent does not cover secondary biomarker use
Study milestones from CTMS (INT-06)
| Milestone | Due | Completed | Status | Evidence / note | Late days |
|---|---|---|---|---|---|
| Eligibility screening | 01 Jun 2026 | 28 May 2026 | Completed | Rejected: sample consent does not cover secondary biomarker use | -4 |
No linked publications
Insights citing the evidence gap "Predictive biomarkers of response"
No linked insights
No related risks
No dependencies recorded
No audit events for this record
Create, update, approve and export events appear here with user, timestamp, previous and new values.